The Microbiome and Resilience to Sleep and Circadian Disruption
Primary Purpose
Sleep Deprivation, Circadian Dysregulation, Stress
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Insufficient Sleep
Sponsored by
About this trial
This is an interventional basic science trial for Sleep Deprivation focused on measuring Microbiome, Stress, Sleep, Circadian
Eligibility Criteria
Inclusion Criteria:
- Healthy
- Currently residing at Denver altitude or higher
Exclusion Criteria:
- Current major medical disorder
Sites / Locations
- Sleep and Chronobiology LaboratoryRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Baseline
Insufficient Sleep
Arm Description
8 hour sleep opportunity at habitual sleep/wake times for 14 days at home and 1 day in lab. Repeated for visit 1 and visit 2.
3 days with 3 hour sleep opportunities in lab, immediately following baseline on both visit 1 and visit 2.
Outcomes
Primary Outcome Measures
Change in fecal microbiome
Fecal "beta diversity" (unit=weighted UniFrac)
Change in fecal metabolome
Fecal small molecules (Mass spect metabolite abundance)
Secondary Outcome Measures
Visual Search Performance
Cognitive Throughput (items/minute)
Maintenance of wakefulness test
Average latency to falling asleep (minutes)
Karolinska Sleepiness Scale
Single question likert scale: Total score reported with a range of 1-9; min score=1[very alert], maximum score=9[very sleepy, great effort to keep awake, fighting sleep]. A higher score representing higher sleepiness. A lower score represents less sleepiness and a better outcome.
Changes in plasma metabolome
Plasma small molecules (Mass spect metabolite abundance)
Full Information
NCT ID
NCT03747367
First Posted
November 14, 2017
Last Updated
October 29, 2020
Sponsor
University of Colorado, Boulder
Collaborators
University of California, San Diego, Office of Naval Research (ONR)
1. Study Identification
Unique Protocol Identification Number
NCT03747367
Brief Title
The Microbiome and Resilience to Sleep and Circadian Disruption
Official Title
The Microbiome and Responsiveness to Stress: Countermeasure Strategies for Improving Resilience to Sleep and Circadian Disruption (Experiments 1 & 2)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 21, 2015 (Actual)
Primary Completion Date
May 2021 (Anticipated)
Study Completion Date
September 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Colorado, Boulder
Collaborators
University of California, San Diego, Office of Naval Research (ONR)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is about how sleep loss and being awake at night impacts the ability to think, changes molecules in the blood, and alters the bacteria that live in the gut that typically help keep people healthy. This work will have important implications for the development of treatments and countermeasures for people who do not sleep enough and need to be active at different times of the day and night (e.g., emergency workers and military personnel).
Detailed Description
Experiment 1: Consistency of microbiota-gut-brain axis responses
Prior to the start of this study, there are screening procedures to ensure participants meet the criteria for the study. At the first consent screening appointment, participants will learn more about the study, answer questionnaires, and complete a psychological interview. At the second medical screening appointment, participants will have a physical exam, blood work, drug screen, pregnancy test, electrocardiogram (a measurement of heart activity), and a resting metabolic rate assessment (a measurement of how much energy the body uses at rest). Participants will also meet with a nutritionist to discuss their food preferences for the study. Although participants are not financially compensated for the screening procedures, the expense of the screening tests is covered and copies are provided to the participant upon request. All of the results of the screening procedures are confidential and will only be used by the study staff to determine eligibility for the study.
Following the screening procedures, participants will complete two laboratory visits, both visits preceded by two weeks of home activity monitoring. During the home monitoring, participants wear a special watch that records activity levels. Participants also keep a sleep/wake log and use a website to log their daily sleep/wake times (if participants cannot access this website, they can call into an answering machine to inform investigators when they go to bed and wake up each day). The investigators will provide participants with a pre-study diet prepared by study dieticians for participants to eat for the three days prior to the laboratory visit. During the two weeks between the first and second laboratory visit participants will continue to wear the special watch, keep a sleep/wake log, and use a website to log their daily sleep/wake times (or call them into the answering machine). Participants will again be given a pre-study diet for the three days prior to their second visit.
During the laboratory visits, participants will live in the Sleep and Chronobiology Lab at the University of Colorado at Boulder for 3.7 days on two different occasions. The day before the inpatient visit begins, participants will spend the night in the laboratory, sleeping their normal 8 hours. This will be used as a pre-study screening for problems with sleep. In the morning participants will complete some pre-study tests and samples which will take approximately 60 minutes. Participants will then be permitted to leave the laboratory and in the evening they will return to begin the study. During the study participants sleep schedule will be changed to simulate the sleep loss that emergency workers in medical and military situations experience. Participants will be given an initial 3 hour sleep opportunity and then kept awake overnight. Throughout the study participants will be given a 3 hour sleep opportunity for every 24 hours of the laboratory visit. While participants are awake, they will be asked to perform a number of computer tasks, including a driving simulator. Blood and saliva samples will be taken to test for circadian and metabolic markers. Participants will also be asked to collect samples of the bacteria that live in their gastrointestinal tract from used bathroom tissue after they use the bathroom in the study. Finally, investigators will test how the heart and nervous system respond to stress by having participants place their hand in an ice water bath. At the end of the laboratory visit participants will be given an 11 hour sleep opportunity to recover from their sleep loss. After 3 more days of recovery sleep and another 2 weeks of home monitoring (identical to the first two weeks of the study), these procedures will be repeated in a second laboratory visit.
Experiment 2: Pre-biotic
Methods for experiment 2 are exactly the same as experiment 1 with the following addition: During the two weeks prior to laboratory visits, half of the study participants will be randomized (e.g., flip of a coin) to receive the prebiotic combination of polydextrose (PDX) and galacto-oligosaccharides (GOS) daily for 2 weeks and then tested in the first in-laboratory visit. These participants will then receive a maltodextrin placebo (a starch-derived food additive commonly used as a filling agent in a range of commercial foods and beverages) the two weeks prior to the second in-laboratory visit. The other half of participants will first receive maltodextrin and then the prebiotic diet. Investigators will provide participants the prebiotics and maltodextrin powders to be mixed in water and consumed each morning. The order in which participants receive the prebiotic diet will be maintained by the Clinical and Translational Research Center pharmacist. Neither the investigators nor participants will know what is in the powder provided.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Deprivation, Circadian Dysregulation, Stress
Keywords
Microbiome, Stress, Sleep, Circadian
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Experiment 1 - Single group, repeated assessment Experiment 2 - Double-blind, randomized, cross-over design
Masking
ParticipantInvestigator
Masking Description
Experiment 1 - none Experiment 2 - double-blind
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Baseline
Arm Type
No Intervention
Arm Description
8 hour sleep opportunity at habitual sleep/wake times for 14 days at home and 1 day in lab. Repeated for visit 1 and visit 2.
Arm Title
Insufficient Sleep
Arm Type
Experimental
Arm Description
3 days with 3 hour sleep opportunities in lab, immediately following baseline on both visit 1 and visit 2.
Intervention Type
Behavioral
Intervention Name(s)
Insufficient Sleep
Primary Outcome Measure Information:
Title
Change in fecal microbiome
Description
Fecal "beta diversity" (unit=weighted UniFrac)
Time Frame
Daily fecal samples while living in laboratory (3 samples per visit, 2 laboratory visits as part of a 39 day protocol)
Title
Change in fecal metabolome
Description
Fecal small molecules (Mass spect metabolite abundance)
Time Frame
Daily fecal samples while living in laboratory (3 samples per visit, 2 laboratory visits as part of a 39 day protocol)
Secondary Outcome Measure Information:
Title
Visual Search Performance
Description
Cognitive Throughput (items/minute)
Time Frame
Assessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol)
Title
Maintenance of wakefulness test
Description
Average latency to falling asleep (minutes)
Time Frame
Assessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol)
Title
Karolinska Sleepiness Scale
Description
Single question likert scale: Total score reported with a range of 1-9; min score=1[very alert], maximum score=9[very sleepy, great effort to keep awake, fighting sleep]. A higher score representing higher sleepiness. A lower score represents less sleepiness and a better outcome.
Time Frame
Assessed every 3 hours daily while living in the laboratory (17 times per visit, 2 laboratory visits as part of a 39 day protocol)
Title
Changes in plasma metabolome
Description
Plasma small molecules (Mass spect metabolite abundance)
Time Frame
Assessed ~every 6 hours while living in the laboratory (10 times per visit, 2 laboratory visits as part of a 39 day protocol)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy
Currently residing at Denver altitude or higher
Exclusion Criteria:
Current major medical disorder
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sleep and Chronobiology Laboratory
Phone
303 735 1923
Email
sleep.study@colorado.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Wright, PhD
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sleep and Chronobiology Laboratory
City
Boulder
State/Province
Colorado
ZIP/Postal Code
80309-0554
Country
United States
Individual Site Status
Recruiting
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Any data generated from the proposed work that is presented in a peer reviewed journal will be de-identified.
Microbiome data will be deposited in the International Nucleotide Sequence Database Collaboration www.insdc.org/ and is already deposited in Qiita http://qiita.microbio.me
Metabolomics data will be deposited in Global Natural Products Social (GNPS) molecular networking http://gnps.ucsd.edu
Other data that is presented in a peer reviewed journal will be archived indefinitely and made available upon request.
IPD Sharing Time Frame
Upon publication, microbiome data to be deposited permanently in International Nucleotide Sequence Database Collaboration www.insdc.org/ Data already deposited in Qiita http://qiita.microbio.me Upon publication, metabolomics data to be deposited permanently in Global Natural Products Social (GNPS) molecular networking http://gnps.ucsd.edu
IPD Sharing Access Criteria
data will be freely available at www.insdc.org/ and http://gnps.ucsd.edu
Learn more about this trial
The Microbiome and Resilience to Sleep and Circadian Disruption
We'll reach out to this number within 24 hrs